Par Pharmaceutical Recalls Pramipexole Dihydrochloride Extended Release Tablets
Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because they contain a known impurity above approved specification levels.
- Product
- Pramipexole Dihydrochloride Extended Release Tablets, 0.375 mg, Rx Only, 30 count bottles, Manufactured By: Par Pharmaceutical Companies, Inc., Chestnut Ridge, NY 10977, NDC 10370-251-11
- Category
- Drug
- Distribution
- Distributed nationwide